Want to see KR:006280 full AI Analyst Report?
GC Biopharma Corp. (006280) Ownership - Who Owns GC Biopharma Corp.?
GC Biopharma Corp. (006280) Ownership Overview
- 2.47% Mutual Funds
- 3.21% ETFs
- 94.32% Public Companies and Individual Investors
The ownership structure of GC Biopharma Corp. (KR:006280) stock is a mix of institutional, retail, and individual investors. Approximately 5.68% of the company’s stock is owned by Institutional Investors, and 94.32% is owned by Public Companies and Individual Investors.
The ownership structure of GC Biopharma Corp. (KR:006280) stock is a mix of institutional, retail, and individual investors. Approximately 5.68% of the company’s stock is owned by Institutional Investors, and 94.32% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
| Date | Name | Activity | Value |
|---|
Recent Hedge Fund Trading Activity
| Date | Firm | Activity | Value |
|---|
Top Shareholders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Vanguard | 163,473 | Institution | 1.40% | 15,961,994 |
| Ishares | 141,751 | Institution | 1.21% | 13,840,993 |
| Vanguard Star Funds | 79,614 | Institution | 0.68% | 7,773,750 |
| Old Westbury Funds Inc | 65,254 | Institution | 0.56% | 6,371,596 |
| Vanguard Tax-managed Funds | 52,610 | Institution | 0.45% | 5,136,998 |
| Tiaa-cref Funds | 31,553 | Institution | 0.27% | 3,080,930 |
| Dfa Investment Dimensions Group Inc | 30,475 | Institution | 0.26% | 2,975,670 |
| Avantis | 23,541 | Institution | 0.20% | 2,298,614 |
| Vanguard International Equity Index Funds | 22,145 | Institution | 0.19% | 2,162,304 |
| Dimensional | 20,808 | Institution | 0.18% | 2,031,756 |
Top Mutual Fund Holders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Vanguard Star Funds | 79,614 | Institution | 0.68% | 7,773,750 |
| Old Westbury Funds Inc | 65,254 | Institution | 0.56% | 6,371,596 |
| Vanguard Tax-managed Funds | 52,610 | Institution | 0.45% | 5,136,998 |
| Tiaa-cref Funds | 31,553 | Institution | 0.27% | 3,080,930 |
| Dfa Investment Dimensions Group Inc | 30,475 | Institution | 0.26% | 2,975,670 |
| Vanguard International Equity Index Funds | 22,145 | Institution | 0.19% | 2,162,304 |
| Fidelity Salem Street Trust | 3,489 | Institution | 0.03% | 340,676 |
| State Street Institutional Investment Trust | 1,262 | Institution | 0.01% | 123,225 |
| Eaton Vance Series Trust Ii | 1,257 | Institution | 0.01% | 122,737 |
| American Century Etf Trust | 482 | Institution | <0.01% | 47,064 |
Top ETF Holders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Vanguard, VXUS ETF | 79,614 | Institution | 0.68% | 7,188,134 |
| iShares, IEMG ETF | 72,400 | Institution | 0.62% | 7,147,178 |
| Vanguard, VEA ETF | 52,610 | Institution | 0.45% | 4,750,013 |
| Avantis, AVEM ETF | 18,444 | Institution | 0.16% | 1,820,753 |
| Vanguard, VSS ETF | 17,123 | Institution | 0.15% | 1,545,989 |
| iShares, IXUS ETF | 11,584 | Institution | 0.10% | 1,143,548 |
| Schwab, SCHC ETF | 9,999 | Institution | 0.09% | 987,556 |
| State Street, SPDW ETF | 7,239 | Institution | 0.06% | 714,963 |
| Dimensional, DFEM ETF | 7,177 | Institution | 0.06% | 708,840 |
| Vanguard, VPL ETF | 5,947 | Institution | 0.05% | 536,938 |
FAQ
What percentage of GC Biopharma Corp. (KR:006280) stock is held by institutional investors?
According to the latest TipRanks data, approximately 5.68% of GC Biopharma Corp. (KR:006280) stock is held by institutional investors: 2.47% by mutual funds and 3.21% by ETFs.
What percentage of GC Biopharma Corp. (KR:006280) stock is held by retail investors?
According to the latest TipRanks data, approximately 94.32% of GC Biopharma Corp. (KR:006280) stock is held by public companies and individual investors.
Who owns the most shares of GC Biopharma Corp. (KR:006280)?
Vanguard owns the most shares of GC Biopharma Corp. (KR:006280).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.